RESUMEN
Ammonia is a major neurotoxic substance associated with the complex pathogenesis of hepatic encephalopathy. Although several primary and secondary conditions have been reported to cause hyperammonemia, in veterinary medicine this condition is considered primarily associated with hepatic disease or portosystemic shunting. Only a few cases of inherited urea cycle enzyme deficiency and organic acid metabolic disorders have been reported in cats with hyperammonemia. To the best of our knowledge, this is the first report of hyperammonemia in a cat caused by accumulation of methylmalonic acid (MMA) secondary to functional cobalamin deficiency. A 2-year-old spayed female Turkish Angora cat exhibited postprandial depression with a 3-month history of hyperammonemia. Serum protein C and bile acid concentrations were normal. Plasma amino acid analysis revealed a deficiency of urea cycle amino acids. Although the serum cobalamin concentration was markedly high, there was no evidence of inflammatory, hepatic, or renal disease or neoplasia on blood, ultrasonographic, and computed tomographic examination. Gas chromatography-mass spectrometry revealed a high MMA concentration in the urine. Based on the results, functional cobalamin deficiency was diagnosed. Following oral amino acid supplementation and initiation of a low-protein diet, the serum ammonia level returned to normal and the postprandial depression improved. Urea cycle amino acid deficiency secondary to functional cobalamin deficiency presumably caused hyperammonemia due to MMA accumulation in this case.
Hyperammoniémie féline associée à un déficit fonctionnel en cobalamine : rapport de cas. L'ammoniac est une substance neurotoxique majeure associée à la pathogenèse complexe de l'encéphalopathie hépatique. Bien que plusieurs affections primaires et secondaires aient été signalées comme étant à l'origine d'une hyperammoniémie, en médecine vétérinaire, cette affection est considérée comme principalement associée à une maladie hépatique ou à un shunt porto-systémique. Seuls quelques cas de déficit héréditaire en enzymes du cycle de l'urée et de troubles métaboliques des acides organiques ont été signalés chez des chats atteints d'hyperammoniémie. À notre connaissance, il s'agit du premier rapport d'hyperammoniémie chez un chat causée par une accumulation d'acide méthylmalonique (MMA) secondaire à un déficit fonctionnel en cobalamine.Une chatte angora turque stérilisée âgée de 2 ans a présenté une dépression postprandiale avec une histoire d'hyperammoniémie depuis 3 mois. Les concentrations sériques de protéine C et d'acides biliaires étaient normales. L'analyse plasmatique des acides aminés a révélé une déficience en acides aminés du cycle de l'urée. Bien que la concentration sérique de cobalamine ait été nettement élevée, il n'y avait aucun signe de maladie inflammatoire, hépatique ou rénale ou de néoplasie à l'examen sanguin, échographique et tomodensitométrique. La chromatographie en phase gazeuse-spectrométrie de masse a révélé une forte concentration de MMA dans l'urine. Sur la base des résultats, un déficit fonctionnel en cobalamine a été diagnostiqué. Après une supplémentation orale en acides aminés et la mise en place d'un régime pauvre en protéines, le taux sérique d'ammoniac est revenu à la normale et la dépression postprandiale s'est améliorée. Une carence en acides aminés du cycle de l'urée secondaire à une carence en cobalamine fonctionnelle a vraisemblablement causé une hyperammoniémie due à l'accumulation de MMA dans ce cas.(Traduit par Dr Serge Messier).
Asunto(s)
Enfermedades de los Gatos , Hiperamonemia , Deficiencia de Vitamina B 12 , Gatos , Animales , Femenino , Hiperamonemia/etiología , Hiperamonemia/veterinaria , Hiperamonemia/diagnóstico , Amoníaco , Deficiencia de Vitamina B 12/complicaciones , Deficiencia de Vitamina B 12/diagnóstico , Deficiencia de Vitamina B 12/veterinaria , Vitamina B 12/uso terapéutico , Ácido Metilmalónico/orina , Aminoácidos , Urea , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Gatos/etiologíaRESUMEN
A 5-month-old intact male domestic shorthair cat presenting for routine vaccinations was diagnosed with congenital hypothyroidism. His primary presenting symptom was incomplete dentition with delayed dental eruption. Congenital hypothyroidism was confirmed by baseline thyroxine (T4), free T4, and thyroid-stimulating hormone testing. The cat was treated with oral thyroid hormone supplementation and 16 weeks after initiation of therapy the cat was clinically normal with age-appropriate dentition. No surgical intervention was necessary to achieve normal dental eruption.
Asunto(s)
Enfermedades de los Gatos , Hipotiroidismo Congénito , Masculino , Gatos , Animales , Hipotiroidismo Congénito/diagnóstico , Hipotiroidismo Congénito/tratamiento farmacológico , Hipotiroidismo Congénito/etiología , Hipotiroidismo Congénito/veterinaria , Tiroxina/uso terapéutico , Tirotropina , Enfermedades de los Gatos/tratamiento farmacológico , Enfermedades de los Gatos/etiologíaRESUMEN
Given the importance of using the vitamin-mineral supplements to guarantee the minimum nutritional recommendations for pets in homemade foods, and hypothesizing that these products may contribute to toxic metals contamination, the present study aimed to determine the concentrations of essential minerals and toxic metals in vitamin-mineral supplements available in the Brazilian market and calculate if the amount recommended by the manufacturer guarantees the minimum recommendations of NRC (2006) and FEDIAF (2020), as well as calculating the amount of toxic metals that animals would consume, according to the amounts recommended by the manufacturer. Seven vitamin-mineral supplements were analyzed. The determination of essential minerals and toxic metals was performed using ICP-OES. Comparisons were made with the minimum recommendations for essential minerals, and with the maximum tolerated levels of toxic metals established by the FDA (2011), descriptively. Most of the vitamin-mineral supplements, in the quantities recommended by the manufacturers, do not guarantee the minimum recommendations of NCR (2006) and FEDIAF (2020) for the following elements: calcium, potassium, magnesium, sodium, phosphorus, selenium, and zinc. Only one supplement had detectable selenium concentrations. Three supplements provided more than 0.02mg of mercury/kg of body weight, the safe upper limit used to establish the maximum tolerated level of this element. It is concluded that most vitamin-mineral supplements do not meet the minimum recommendations for most essential minerals and, if formulated by untrained professionals, even with supplementation, homemade foods may still be nutritionally deficient. Furthermore, some vitamin-mineral supplements analyzed may imply risks of mercury poisoning in pets.
Asunto(s)
Suplementos Dietéticos/efectos adversos , Intoxicación por Mercurio/etiología , Minerales/análisis , Vitaminas/análisis , Animales , Enfermedades de los Gatos/etiología , Gatos , Suplementos Dietéticos/análisis , Enfermedades de los Perros/etiología , Perros , Magnesio/análisis , Minerales/administración & dosificación , Selenio/análisis , Vitaminas/administración & dosificación , Zinc/análisisRESUMEN
BACKGROUND: Chronic kidney disease (CKD) and acute decompensation of CKD (ACKD) are common in cats. OBJECTIVES: To characterize the etiology, clinical and clinicopathologic findings, and the short- and long-term prognosis of feline ACKD. ANIMALS: One hundred cats with ACKD. METHODS: Retrospective study, search of medical records for cats with ACKD. RESULTS: Common clinical signs included anorexia (85%), lethargy (60%), weight loss (39%), and vomiting (27%). Suspected etiologies included ureteral obstruction (11%), renal ischemia (9%), pyelonephritis (8%), others (6%), or unknown (66%). Hospitalization duration was longer in survivors versus nonsurvivors (median = 7 days, range = 2-26 versus median = 3 days, range = 2-20, respectively, P < .001). The survival rate to discharge was 58%. Age, serum creatinine, urea, and phosphorous concentrations were higher and venous blood pH was lower in nonsurvivors. However, only serum phosphorus remained associated with the short-term outcome in the multivariable model (P = .02; 95% confidence interval = 1.03-1.39). Survivors had a median survival time of 66 days after discharge. Serum creatinine concentrations at presentation as well as at discharge were associated with long-term survival (P < .002 for both). CONCLUSIONS: The short-term prognosis of ACKD is comparable to acute kidney injury, while the long-term prognosis is guarded.
Asunto(s)
Lesión Renal Aguda/veterinaria , Enfermedades de los Gatos/etiología , Insuficiencia Renal Crónica/veterinaria , Lesión Renal Aguda/sangre , Lesión Renal Aguda/etiología , Animales , Enfermedades de los Gatos/sangre , Enfermedades de los Gatos/patología , Gatos , Creatinina/sangre , Femenino , Hospitalización/estadística & datos numéricos , Isquemia , Riñón/irrigación sanguínea , Masculino , Fósforo/sangre , Pronóstico , Protones , Pielonefritis/veterinaria , Insuficiencia Renal Crónica/sangre , Estudios Retrospectivos , Urea/sangre , Obstrucción Ureteral/veterinariaRESUMEN
OBJECTIVES: Vitamin D deficiency accompanies chronic cholestatic liver disease (CLD) in humans. The vitamin D status of cats with CLD is unknown. The objectives of this study were to describe serum vitamin D concentrations in cats with CLD and to determine if they correlated with indices of liver disease severity. METHODS: Thirty-six cats with CLD, defined by increases in serum bilirubin and serum alanine aminotransferase, and 23 sick cats with non-hepatobiliary diseases were prospectively enrolled. Serum 25-hydroxyvitamin D (25[OH]D), parathyroid hormone (PTH) and ionized calcium were measured. Signalment, clinical signs, comorbidities, diet history, serum bilirubin, liver enzyme activity, albumin, phosphorus, white blood cell count, prothrombin time and final hepatic cytologic/histopathologic diagnosis, when available, were recorded. RESULTS: Median serum 25(OH)D levels were similar in cats with CLD (89.5 nmol/l; range 21-112 nmol/l) and sick cats (89.0 nmol/l; range 49-115 nmol/l). Overall 12/36 (33%) cats with CLD and 4/23 (17%) sick cats had 25(OH)D levels below the lower limit of the reference interval (<65 nmol/l). Median PTH concentrations in cats with CLD were significantly higher (0.95 pmol/l; range 0-11.3 pmol/l) than in sick cats (0.70 pmol/l; range 0.5-6 pmol/l). In cats with CLD, 6/36 (17%) had high PTH levels in contrast to only 1/23 (4%) sick cats. In cats with CLD, 25(OH)D concentrations did not correlate with serum bilirubin, albumin or serum liver enzymes but were moderately negatively correlated with white blood cell count (r = - 0.402, P = 0.013). Cats with hepatic lipidosis had the highest prevalence of 25(OH)D concentrations that fell below the reference interval. CONCLUSIONS AND RELEVANCE: Many cats with CLD have serum 25(OH)D concentrations below the lower limit of the reference interval. Further study is warranted to determine the clinical relevance and whether supplementation would provide benefits.
Asunto(s)
Enfermedades de los Gatos/epidemiología , Hepatopatías/veterinaria , Deficiencia de Vitamina D/veterinaria , Vitamina D/sangre , Animales , Enfermedades de los Gatos/sangre , Enfermedades de los Gatos/etiología , Gatos , Hepatopatías/sangre , Hepatopatías/etiología , Massachusetts/epidemiología , Proyectos Piloto , Prevalencia , Índice de Severidad de la Enfermedad , Deficiencia de Vitamina D/sangre , Deficiencia de Vitamina D/etiologíaRESUMEN
OBJECTIVES: The aim of this study was to assess the effect of three oral potassium supplements (potassium gluconate tablets [PGT], potassium gluconate granules [PGG] and potassium citrate granules [PCG]) on hypokalemia and serum bicarbonate in cats with chronic kidney disease (CKD). METHODS: Medical records (2006-2016) were retrospectively searched for cats that had been prescribed an oral potassium supplement for management of their CKD-associated hypokalemia. For inclusion, laboratory work had to be available at the time of hypokalemia diagnosis, and at recheck within 1-6 weeks. Treatment response was defined in three ways: any increase in potassium, an increase in potassium to within the normal reference interval, and an increase to >4 mEq/l. RESULTS: Thirty-seven cats met inclusion criteria (16 PGT, 11 PGG, 10 PCG). Dosing ranged from 0.21 to 1.6 mEq/kg/day for PGT, from 0.25 to 1.48 mEq/kg/day for PGG and from 0.04 to 1.34 mEq/kg/day for PCG. After supplementation, 36/37 cats had an increase in potassium, 34/37 increased to within the reference interval and 24/37 had an increase in potassium to >4 mEq/l. There was a statistically significant difference in serum potassium post-supplementation for all three treatments: PGT (P = 0.0001), PGG (P = 0.001) and PCG (P = 0.002). There was a positive correlation between PGT dose and change in potassium concentration (P = 0.04), but there was no significant correlation for PGG or PCG. In cats that had data available, serum bicarbonate increased >2 mEq/l in 1/6 PGT, 1/6 PGG and 3/4 PCG cats. CONCLUSIONS AND RELEVANCE: All three potassium supplements were effective in treating hypokalemia secondary to CKD in the majority of cats despite variable dosing. Data were limited to assess the alkalinizing effect and prospective studies are needed.
Asunto(s)
Bicarbonatos/sangre , Enfermedades de los Gatos/tratamiento farmacológico , Hipopotasemia/veterinaria , Citrato de Potasio/metabolismo , Compuestos de Potasio/metabolismo , Insuficiencia Renal Crónica/veterinaria , Alimentación Animal/análisis , Animales , Enfermedades de los Gatos/etiología , Gatos , Dieta/veterinaria , Suplementos Dietéticos , Femenino , Hipopotasemia/tratamiento farmacológico , Hipopotasemia/etiología , Masculino , Citrato de Potasio/administración & dosificación , Compuestos de Potasio/administración & dosificación , Insuficiencia Renal Crónica/complicaciones , Estudios RetrospectivosRESUMEN
Transrectal electrostimulation is a technique used for semen collection in several animals including felids, but also in humans with spinal cord injuries and in specific cases of anejaculation. To the authors' knowledge, safety and innocuity on rectal mucosa has not yet been assessed histologically. A prospective study was performed on 10 European cats in order to determine the impact of electroejaculation on the rectal mucosa, by performing endoscopic and histological evaluation of the rectal mucosa. Endoscopic evaluation was performed before and after semen collection. Standardized biopsy specimens were collected immediately after semen collection, on the site of electrostimulation and on the proximal part of the descending colon as a control, for further double-blinded histopathological evaluation. The degree of inflammation was evaluated following the criteria from the WSAVA Gastrointestinal Standardization Group. Semen collection by electrostimulation did not induce significant histological and endoscopic lesions. Electrostimulation may therefore be considered as a safe technique to collect semen in cats.
Asunto(s)
Enfermedades de los Gatos/etiología , Eyaculación , Estimulación Eléctrica/efectos adversos , Manejo de Especímenes/veterinaria , Animales , Enfermedades de los Gatos/patología , Gatos , Colon/patología , Enfermedades del Colon/veterinaria , Masculino , SemenRESUMEN
CASE REPORT: A male Domestic Short-hair cat was presented for chronic weight loss, lethargy and hyporexia. Complete haematological examination revealed non-regenerative anaemia, neutropenia and thrombocytopenia, as well as Howell-Jolly bodies, anisocytosis, polychromasia and macrocytosis on blood smear evaluation. Histopathological evaluation of bone marrow biopsy disclosed hypocellularity consistent with bone marrow failure. Concurrent hypocobalaminaemia was identified and treated with parenteral cyanocobalamin supplementation. Other differential diagnoses for pancytopenia, including infectious, toxic, immune-mediated and neoplastic causes, were ruled out. CONCLUSION: The cat's erythrocyte, leucocyte and platelet counts normalised after 2 months of cyanocobalamin supplementation, suggesting that pancytopenia may be a rare manifestation of feline cobalamin deficiency.
Asunto(s)
Enfermedades de los Gatos/etiología , Pancitopenia/veterinaria , Deficiencia de Vitamina B 12/veterinaria , Animales , Bario/uso terapéutico , Médula Ósea/patología , Enfermedades de los Gatos/sangre , Enfermedades de los Gatos/tratamiento farmacológico , Enfermedades de los Gatos/patología , Gatos , Diagnóstico Diferencial , Masculino , Pancitopenia/tratamiento farmacológico , Pancitopenia/etiología , Pancitopenia/patología , Vitamina B 12/uso terapéutico , Deficiencia de Vitamina B 12/complicaciones , Deficiencia de Vitamina B 12/tratamiento farmacológicoRESUMEN
Phosphorus, or phosphate, is the body's major intracellular anion involved in numerous biological processes. Most phosphate is intracellular, with the remaining amount contained within soft tissues and the extracellular space. Parathyroid hormone, calcitriol, calcitonin, and phosphatonins regulate normal phosphate homeostasis by adjusting renal and/or gastrointestinal absorption and/or excretion. Hypophosphatemia occurs secondary to decreased gastrointestinal absorption, transcellular shifts, increased renal excretion, or some combination of these general mechanisms. Hyperphosphatemia results from decreased renal excretion, increased intake or iatrogenic administration, transcellular shifts, or some combination of these.
Asunto(s)
Enfermedades de los Gatos , Enfermedades de los Perros , Trastornos del Metabolismo del Fósforo/veterinaria , Animales , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Gatos/etiología , Enfermedades de los Gatos/terapia , Gatos , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/etiología , Enfermedades de los Perros/terapia , Perros , Fosfatos/farmacología , Fósforo/farmacología , Trastornos del Metabolismo del Fósforo/diagnóstico , Trastornos del Metabolismo del Fósforo/etiología , Trastornos del Metabolismo del Fósforo/terapia , Valores de ReferenciaRESUMEN
Acarbose (AC) and Sitagliptin (STGP) are oral hypoglycemic agents currently used either alone or in conjunction with human diabetic (Type 2) patients. AC has been used with diabetic cats, but not STGP thus far. Therefore, the objective of this study was to determine the potential use of AC or STGP alone and in combination for diabetic cats, by observing their effect on short-term post-prandial serum glucose, insulin, and incretin hormone (active glucagon-like peptide-1 (GLP-1) and total glucose dependent insulinotropic polypeptide (GIP)) concentrations in five healthy cats, following ingestion of a meal with maltose. All treatments tended (p<0.10; 5-7.5% reduction) to reduce postprandial glucose area under the curve (AUC), with an accompanying significant reduction (p<0.05, 35-45%) in postprandial insulin AUC as compared to no treatment. Meanwhile, a significant increase (p<0.05) in postprandial active GLP-1 AUC was observed with STGP (100% higher) and combined treatment (130% greater), as compared to either AC or no treatment. Lastly, a significant reduction (p<0.05) in postprandial total GIP AUC was observed with STGP (21% reduction) and combined treatment (7% reduction) as compared to control. Overall, AC, STGP, or combined treatment can significantly induce positive post-prandial changes to insulin and incretin hormone levels of healthy cats. Increasing active GLP-1 and reducing postprandial hyperglycemia appear to be the principal mechanisms of combined treatment. Considering the different, but complementary mechanisms of action by which AC and STGP induce lower glucose and insulin levels, combination therapy with both these agents offers great potential for treating diabetic cats in the future.
Asunto(s)
Acarbosa/efectos adversos , Enfermedades de los Gatos/tratamiento farmacológico , Hiperglucemia/veterinaria , Hipoglucemiantes/efectos adversos , Fosfato de Sitagliptina/efectos adversos , Animales , Glucemia/análisis , Enfermedades de los Gatos/etiología , Gatos , Quimioterapia Combinada/veterinaria , Femenino , Hiperglucemia/tratamiento farmacológico , Hiperglucemia/etiología , Incretinas/sangre , Insulina/sangre , MasculinoRESUMEN
Two 4-year-old spayed female Siamese cats were seized by the British Columbia Society for the Prevention of Cruelty to Animals after confinement to an abandoned housing unit without food for 9 weeks. One cat was found dead, and the second was euthanized within 24 hours due to neurologic deterioration despite therapy. Polioencephalomalacia of the caudal colliculus, hepatic lipidosis, cachexia, and congestive heart failure with cardiomyocyte atrophy were identified in both cats through postmortem examination and attributed to a prolonged period of starvation. Brain lesions were likely the result of thiamine deficiency (Chastek paralysis), which can be associated with both malnutrition and liver disease. This case highlights the importance of thiamine supplementation during realimentation of cats with hepatic lipidosis. Heart failure resulting from cachexia may have contributed to the death of the first cat and the morbidity of the second cat.
Asunto(s)
Enfermedades de los Gatos/etiología , Encefalomalacia/veterinaria , Insuficiencia Cardíaca/veterinaria , Lipidosis/veterinaria , Hepatopatías/veterinaria , Deficiencia de Tiamina/veterinaria , Animales , Enfermedades de los Gatos/patología , Gatos , Suplementos Dietéticos , Encefalomalacia/etiología , Encefalomalacia/patología , Resultado Fatal , Femenino , Insuficiencia Cardíaca/etiología , Insuficiencia Cardíaca/patología , Lipidosis/complicaciones , Lipidosis/patología , Hepatopatías/etiología , Hepatopatías/patología , Inanición/complicaciones , Inanición/patología , Inanición/veterinaria , Tiamina/metabolismo , Deficiencia de Tiamina/complicaciones , Deficiencia de Tiamina/patologíaRESUMEN
We aimed to examine the early effects of prepubertal ovariohysterectomy (P-OHE) on bone loss and proximal physeal closure in cats. Fourteen kittens randomly underwent P-OHE or sham operations (S-OP) at three months (mo) of age and were allocated to group I and group II. Each mo between four and nine mo of age, dual-energy X-ray absorptiometry (DEXA) scans were performed to determine the total body bone mineral density (BMD) and bone mineral content (BMC). Proximal radial physeal closure and radial length were determined by radiography. Bone-specific alkaline phosphatase (BAP), carboxy-terminal collagen teleopeptide (CTX), 17-ß estradiol, progesterone, calcium (Ca) and phosphorus (P) were measured in the serum samples. No significant differences were observed between the groups in terms of BMD, BMC, BAP, BAP/CTX, P, progesterone and body weight (BW) (between 4 and 9mo) and for Ca (between 5 and 9mo) and for CTX levels (between 4 and 8mo). The 17-ß estradiol was significantly higher at 6, 8 and 9mo of age in the S-OP group due to puberty (P=0.02, P=0.03 and P=0.02 respectively). Although there was a significant difference (P=0.0002) between the P-OHE and S-OP groups in terms of the proximal radial physeal closure times (7.43±0.20mo and 6.14±0.14mo, respectively), no significant difference was observed for the mean radius length (10.59±0.10cm and 10.06±0.27cm, respectively) at the last evaluation time. In conclusion, prepubertal ovariohysterectomized cats do not have any osteoporotic risks until nine mo of age and exhibit a delayed physeal closure time without a change in radius length.
Asunto(s)
Enfermedades de los Gatos/etiología , Histerectomía/veterinaria , Osteoporosis/veterinaria , Ovariectomía/veterinaria , Absorciometría de Fotón/veterinaria , Fosfatasa Alcalina/sangre , Animales , Calcio/sangre , Gatos/fisiología , Gatos/cirugía , Colágeno Tipo I/sangre , Estradiol/sangre , Histerectomía/efectos adversos , Osteoporosis/etiología , Ovariectomía/efectos adversos , Péptidos/sangre , Fósforo/sangre , Progesterona/sangre , Radio (Anatomía)/crecimiento & desarrollo , Maduración Sexual/fisiologíaRESUMEN
Hypercalcemia is uncommonly encountered in veterinary patients. When it does occur, the effects can be severe, resulting in significant morbidity and mortality if not recognized and addressed in a timely manner. Causes of hypercalcemia are varied and include pituitary-dependent and pituitary-independent causes. A diagnosis of hypercalcemia should be made based on documentation of ionized hypercalcemia. The mainstay of emergency treatment usually involves aggressive IV fluid diuresis, the use of diuretics, and, often, glucocorticoids. The use of bisphosphonates has become increasingly more common in veterinary medicine.
Asunto(s)
Calcio/metabolismo , Enfermedades de los Gatos/diagnóstico , Difosfonatos/uso terapéutico , Enfermedades de los Perros/diagnóstico , Hipercalcemia/veterinaria , Animales , Calcimiméticos/uso terapéutico , Quelantes del Calcio/uso terapéutico , Enfermedades de los Gatos/etiología , Enfermedades de los Gatos/terapia , Gatos , Diuréticos/uso terapéutico , Enfermedades de los Perros/etiología , Enfermedades de los Perros/terapia , Perros , Ácido Edético/uso terapéutico , Fluidoterapia/veterinaria , Galio/uso terapéutico , Homeostasis/fisiología , Hipercalcemia/diagnóstico , Hipercalcemia/etiología , Hipercalcemia/terapia , Plicamicina/uso terapéuticoRESUMEN
Since the first description of feline hyperthyroidism (HT) in 1979, several studies have been undertaken to define the etiology of the disease. Epidemiologic studies, after investigating non-food- and food-associated factors, suggest a multifactorial etiology. However, in the absence of prospective cohort studies that can confirm a cause-and-effect relationship between HT and associated risk factors, no causative factor for HT has been identified to date. Feline HT resembles toxic nodular goiter in humans, with autonomously functioning upregulated iodide uptake systems. Contribution of the diet to HT development remains controversial. The purpose of this paper is to review critically the reported food-associated risk factors for HT.
Asunto(s)
Alimentación Animal , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Gatos/etiología , Suplementos Dietéticos , Hipertiroidismo/veterinaria , Animales , Gatos , Bocio Nodular/veterinaria , Hipertiroidismo/etiología , Hipertiroidismo/prevención & control , Yodo/fisiología , Necesidades Nutricionales , Factores de RiesgoRESUMEN
BACKGROUND: When increased serum cobalamin concentrations are encountered clinically they are usually attributed to parenteral supplementation, dietary factors, or otherwise ignored. However, recently, hypercobalaminaemia has been associated with numerous diseases in humans, most notably neoplastic and hepatic disorders. The aim of this retrospective, observational, cross-sectional study was to determine the significance of increased cobalamin in cats. RESULTS: In total, 237 records were retrieved and 174 cats, of various ages and sexes met the inclusion criteria. A total of 42 cats had increased serum cobalamin concentration, and had not received prior supplementation. Multiple logistic regression analysis revealed that increased serum cobalamin concentration was positively related to pedigree breed (pedigree breeds more likely to have increased cobalamin concentration, odds ratio [OR] 4.24, 95% CI 1.78-10.15, P = 0.001), to having liver disease (OR 9.91, 95% CI 3.54-27.68), and to having a solid neoplasm (OR 8.54, 95% CI 1.10-66.45). CONCLUSIONS: The results of the current study suggest that increased serum cobalamin concentrations should not be ignored in cats with no history of supplementation, and investigation for underlying hepatic or neoplastic disease is warranted.
Asunto(s)
Enfermedades de los Gatos/etiología , Hepatopatías/veterinaria , Neoplasias/veterinaria , Vitamina B 12/sangre , Envejecimiento , Animales , Enfermedades de los Gatos/sangre , Gatos , Estudios Transversales , Femenino , Hepatopatías/sangre , Hepatopatías/complicaciones , Masculino , Neoplasias/sangre , Neoplasias/complicaciones , Oportunidad Relativa , Estudios Retrospectivos , Factores de Riesgo , Sensibilidad y EspecificidadRESUMEN
The medicinal leech, Hirudo medicinalis, has been used for hundreds of years in human medicine for a variety of diseases, most recently including venous congestion following reconstructive surgeries (skin flaps and reimplantations), excessive lingual and periorbital swelling, and non-traditional treatments for osteoarthritis, compartment syndrome and sialoadenitis. The treatment of venous congestion in animals using leeches has been mentioned anecdotally, but the only published report pertains to the use of leeches in a cat suffering from polycythemia vera. We report the use of medical grade leeches in a one-year-old male castrated Domestic Shorthaired cat presenting with severe swelling of the paw after sustaining a constrictive injury from a bandage. The limb use had become compromised and the swelling was not responsive to compression bandages so leech therapy was instituted for four days and the swelling dramatically improved. The patient's limb use improved back to normal and the constrictive wound went on to heal without complication. The use of leeches in this case allowed for resolution of severe venous congestion and a full return to function in this patient with no continued skin loss. The mechanism of action of hirudotherapy for venous congestion is to allow for an alternative egress of pooled venous blood leading to a reduction in capillary pressure and increases in arterial reperfusion of capillary beds. The human and veterinary applications, method, and potential complications with hirudotherapy are discussed in this review.
Asunto(s)
Vendajes/veterinaria , Enfermedades de los Gatos/terapia , Aplicación de Sanguijuelas , Animales , Vendajes/efectos adversos , Mordeduras y Picaduras , Enfermedades de los Gatos/etiología , Gatos , MasculinoRESUMEN
Hypernatremia due to different pathophysiological mechanisms results in a rise in plasma osmolality. Dependent on its severity and on the speed of its development hyperosmolality can be life-threatening. This article describes 2 dogs and 1 cat with central nervous system disorders (adenoma of the pituitary gland, cerebral trauma). All patients developed normovolemic hypernatremia due to pituitary gland and hypothalamus dysfunction, respectively. Plasma sodium concentrations ranged from 163 to 185 mmol/l. Neurological examinations revealed lethargy, disturbances of consciousness, and ataxia, respectively. The dogs had to be euthanased due to the grave prognosis, the cat with cerebral trauma survived.
Le développement d'une hypenatrémie peut avoir plusieurs mécanismes patho-physiologiques. Dans ces cas, il se produit toujours une élévation de l'osmolarité du plasma. Selon l'importance de l'hypernatrémie et la vitesse de l'apparition, une hyperosmolarité peut mettre la vie en danger. Dans le présent article, on décrit des affections du système nerveux central chez deux chiens (adénome de l'hypophyse) et un chat (trauma crânien) ayant développé une hypernatrémie normovolémique suite à un dysfonctionnement de l'hypophyse ou de l'hypothalamus. Les concentrations plasmatiques de sodium étaient comprises entre 163 et 185 mmol/l. Les animaux présentaient de la léthargie, des troubles de la conscience et de l'ataxie. Vu le mauvais pronostic, les chiens ont dû être euthanasiés, le chat victime d'un traumatisme crânien a survécu.
Asunto(s)
Adenoma/veterinaria , Lesiones Encefálicas/veterinaria , Enfermedades de los Gatos/metabolismo , Enfermedades de los Perros/metabolismo , Hipernatremia/veterinaria , Neoplasias Hipofisarias/veterinaria , Adenoma/complicaciones , Adenoma/metabolismo , Animales , Lesiones Encefálicas/complicaciones , Lesiones Encefálicas/metabolismo , Enfermedades de los Gatos/etiología , Gatos , Enfermedades de los Perros/etiología , Perros , Eutanasia Animal , Femenino , Hipernatremia/etiología , Hipernatremia/metabolismo , Hipotálamo/fisiopatología , Masculino , Concentración Osmolar , Hipófisis/fisiopatología , Neoplasias Hipofisarias/complicaciones , Neoplasias Hipofisarias/metabolismo , PronósticoRESUMEN
Of the several thousand species of mushrooms found in North America, less than 100 are toxic. Species in the genus Amanita are responsible for the vast majority of reported mushroom poisonings. In general, the number of reported mushroom poisonings in animals is low, most likely because toxicology testing is available for a limited number of mushroom toxins and thus many cases are not confirmed or reported. Also, only a limited number of mushrooms are submitted for identification purposes. Mushroom intoxications require tremendous efforts from clinicians and toxicologists in terms of making a diagnosis and treatment, and management is challenging.
Asunto(s)
Enfermedades de los Gatos/etiología , Enfermedades de los Perros/etiología , Intoxicación por Setas/veterinaria , Animales , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Gatos/terapia , Gatos , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/terapia , Perros , Intoxicación por Setas/complicaciones , Intoxicación por Setas/diagnóstico , Intoxicación por Setas/terapiaRESUMEN
This retrospective study evaluated the ocular side effects of cancer-bearing dogs and cats treated with external-beam Cobalt-60 (Co-60) radiation in which one or both orbit(s) were included in the radiation field. A total of 37 dogs and 12 cats presented to the Ontario Veterinary College during the 10-year study period (1999-2009) were evaluated. The radiation protocols ranged from a maximum of 60 Gray (Gy) in 24 fractions for curative intent to a minimum of 8 Gy in 1 fraction for palliative treatment. The main ocular side effect reported in both dogs and cats was conjunctivitis (79% and 55%, respectively). Other common ocular side effects included eyelid lesions in dogs (44%), ulcerative keratitis in cats (36%), and keratoconjunctivitis sicca in both dogs and cats (44% and 27%, respectively). The high incidence of ocular side effects in both patient populations indicates a need for regular ophthalmic examinations as a component of routine follow-up for radiation therapy involving the orbit. Radiation damage to ocular tissues is also reviewed.
Étude rétrospective et examen des effets secondaires de la radiation oculaire après une radiothérapie externe au cobalt-60 chez 37 chiens et 12 chats. Cette étude rétrospective a évalué les effets secondaires oculaires chez des chiens et des chats atteints du cancer traités avec une radiation externe au cobalt-60 (Co-60) lorsque l'une ou l'autre des orbites étaient incluses dans le champ de radiation. Un total de 37 chiens et de 12 chats présentés à l'Ontario Veterinary College durant la période d'étude de 10 ans (19992009) ont été évalués. Les protocoles de radiation s'échelonnaient de 60 Gray (Gy) en 24 fractions pour un traitement curatif à un minimum de 8 Gy en 1 fraction pour un traitement palliatif. Le principal effet secondaire oculaire signalé chez les chiens et les chats était la conjonctivite (79 % et 55 %, respectivement). D'autres effets secondaires communs étaient des lésions des paupières chez les chiens (44 %), une kératite ulcérative chez les chats (36 %) et une kératoconjonctivite sèche chez les chiens et les chats (44 % et 27 %, respectivement). L'incidence élevée d'effets secondaires oculaires dans les deux populations de patients signale le besoin d'examens ophtalmologiques réguliers comme élément d'un suivi de routine pour la radiothérapie touchant l'orbite. Les dommages de la radiation aux tissus oculaires sont également examinés.(Traduit par Isabelle Vallières).